Dataset Information

IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T Cells.

ABSTRACT: Interleukin-15 (IL-15) is a cytokine that has been shown to expand CD8 T cell and natural killer (NK) cell populations, and therefore has potential for potentiating adoptive immune cell therapy for cancer. Previously, IL-15 has been shown to induce proliferation of CD8 memory T cells through activation of telomerase. Here, we investigated whether telomerase is also activated during the IL-15 mediated proliferation of NK and NKT-like (CD56+CD3+) cells. We also examined the extent that each of the three signaling pathways known to be stimulated by IL-2/IL-15 (JAK-STAT, PI3K-AKT Ras-RAF/MAPK) were activated and involved in the telomerase expression in the three cell types NK, NKT, or CD8 T cells. To assess cell proliferation and doubling, peripheral blood mononuclear cells (PBMCs) or isolated NK, NKT-like or CD8 T cells were incubated with varying concentrations of IL-15 or IL-2 for 7 days. CD8 T, NK, and NKT cell expansion was determined by fluorophore-conjugated antibody staining and flow cytometry. Cell doubling was investigated using carboxyfluorescein-succinimidyl-ester (CFSE). Telomerase expression was investigated by staining cells with anti-telomerase reverse transcriptase (anti-TERT). Telomerase activity in CD56+ and CD8 T cells was also measured via Telomerase Repeat Amplification Protocol (TRAP). Analysis of cellular expansion, proliferation and TERT expression concluded that IL-15 increased cellular growth of NK, NKT, and CD8 T cells more effectively than IL-2 using low or high doses. IL-15, increased TERT expression in NK and NKT cells by up to 2.5 fold, the same increase seen in CD8 T cells. IL-2 had effects on TERT expression only at high doses (100-1000 ng/ml). Proteome profiling identified that IL-15 activated selected signaling proteins in the three pathways (JAK-STAT, PI3K-AKT, Ras-MAPK) known to mediate IL-2/IL-15 signaling, more strongly than IL-2. Evaluation by signaling pathway inhibitors revealed that JAK/STAT and PI3K/AKT pathways are important in IL-15's ability to upregulate TERT expression in NK and NKT cells, whereas all three pathways were involved in CD8 T cell TERT expression. In conclusion, this study shows that IL-15 potently stimulates TERT upregulation in NK and NKT cells in addition to CD8 T cells and is therefore a valuable tool for adoptive cell therapies.

SUBMITTER: Watkinson F

PROVIDER: S-EPMC7848219 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T Cells.

Watkinson Fiona F Nayar Sandeep Krishan SK Rani Aradhana A Sakellariou Christina A CA Elhage Oussama O Papaevangelou Efthymia E Dasgupta Prokar P Galustian Christine C

Frontiers in immunology 20210118

Interleukin-15 (IL-15) is a cytokine that has been shown to expand CD8 T cell and natural killer (NK) cell populations, and therefore has potential for potentiating adoptive immune cell therapy for cancer. Previously, IL-15 has been shown to induce proliferation of CD8 memory T cells through activation of telomerase. Here, we investigated whether telomerase is also activated during the IL-15 mediated proliferation of NK and NKT-like (CD56+CD3+) cells. We also examined the extent that each of the ...[more]

PMID: 33537030

Similar Datasets

Project description:Pregnancy poses significant metabolic challenges for women, yet the impact of repeated deliveries on overall glucose metabolism in females remains inadequately explored. In this study, we investigate alterations in female glucose metabolism following multiple deliveries using a comprehensive phenotyping mouse model that closely resembles humans. To establish a multiparty mouse model, a 9-week-old female mouse underwent three consecutive pregnancies. Three weeks post-pregnancy, multiparous mice exhibited improved glucose tolerance and enhanced glucose-stimulated insulin secretion (GSIS), without changes in insulin sensitivity compared to virgin mice. Histological analysis revealed an increased beta cell mass in multiparous mice at this stage of life. Intriguingly, 16 weeks after the last delivery, multiparous mice demonstrated impaired glucose tolerance, accompanied by compromised GSIS and increased basal insulin secretion both in vivo and ex vivo. These mice also developed insulin resistance at 16 weeks post-delivery, with no discernible difference in beta cell mass. To assess whether multiparous islets were impaired in their compensatory ability to meet increased insulin demand, multiparous and virgin islets (3 weeks after the last delivery) were transplanted to opposite sides of the kidney capsule in a single recipient mouse. Upon S-961 injection, multiparous mice were reduced in Ki-67 expressing cells compared with virgin mice. Bulk RNA sequencing (RNA-seq) analysis of S-961-injected multiparous islet genes revealed downregulation of cell cycle-related genes (Cenpi and Cenpf, Cdk1, Cdk2, and Cdkn2d). Single-cell RNA-seq analysis identified multiparous-specific beta cell clusters that displayed upregulation of stress-related genes (Ddit3, Fkbp11, Sdf2l1, Nupr1, Atf5, Atf3, Hspa1a, Hspa1b, and Dnajb1). Furthermore, multiparous mice beta cells exhibited shortened telomere lengths and increased expression of Cdkn2a, indicating an accelerated aging phenotype. In humans, women with higher parities (parity > 3 times) exhibited greater impairment in glucose tolerance and increased obesity compared to women with lower parities (parity < 3 times) at 2 months postpartum. Women with higher parity who experienced weight gain after delivery also demonstrated a greater decline in beta cell function (disposition index). Overall, our findings indicate that multiparty increases the risk of diabetes by impairing beta cells ability to compensate for the increased insulin demand.

Project description:The reports on the origin of human CD8(+) Valpha24(+) T-cell receptor (TCR) natural killer T (NKT) cells are controversial. The underlying mechanism that controls human CD4 versus CD8 NKT cell development is not well-characterized. In the present study, we have studied total 177 eligible patients and subjects including 128 healthy latent Epstein-Barr-virus(EBV)-infected subjects, 17 newly-onset acute infectious mononucleosis patients, 16 newly-diagnosed EBV-associated Hodgkin lymphoma patients, and 16 EBV-negative normal control subjects. We have established human-thymus/liver-SCID chimera, reaggregated thymic organ culture, and fetal thymic organ culture. We here show that the average frequency of total and CD8(+) NKT cells in PBMCs from 128 healthy latent EBV-infected subjects is significantly higher than in 17 acute EBV infectious mononucleosis patients, 16 EBV-associated Hodgkin lymphoma patients, and 16 EBV-negative normal control subjects. However, the frequency of total and CD8(+) NKT cells is remarkably increased in the acute EBV infectious mononucleosis patients at year 1 post-onset. EBV-challenge promotes CD8(+) NKT cell development in the thymus of human-thymus/liver-SCID chimeras. The frequency of total (3% of thymic cells) and CD8(+) NKT cells ( approximately 25% of NKT cells) is significantly increased in EBV-challenged chimeras, compared to those in the unchallenged chimeras (<0.01% of thymic cells, CD8(+) NKT cells undetectable, respectively). The EBV-induced increase in thymic NKT cells is also reflected in the periphery, where there is an increase in total and CD8(+) NKT cells in liver and peripheral blood in EBV-challenged chimeras. EBV-induced thymic CD8(+) NKT cells display an activated memory phenotype (CD69(+)CD45RO(hi)CD161(+)CD62L(lo)). After EBV-challenge, a proportion of NKT precursors diverges from DP thymocytes, develops and differentiates into mature CD8(+) NKT cells in thymus in EBV-challenged human-thymus/liver-SCID chimeras or reaggregated thymic organ cultures. Thymic antigen-presenting EBV-infected dendritic cells are required for this process. IL-7, produced mainly by thymic dendritic cells, is a major and essential factor for CD8(+) NKT cell differentiation in EBV-challenged human-thymus/liver-SCID chimeras and fetal thymic organ cultures. Additionally, these EBV-induced CD8(+) NKT cells produce remarkably more perforin than that in counterpart CD4(+) NKT cells, and predominately express CD8alphaalpha homodimer in their co-receptor. Thus, upon interaction with certain viruses, CD8 lineage-specific NKT cells are developed, differentiated and matured intrathymically, a finding with potential therapeutic importance against viral infections and tumors.

Dataset Information

IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T Cells.

Publications

IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T Cells.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets